Cyberounds Logo
September 26, 2020 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Open Angle Glaucoma
CME credit is no longer available for this conference.
Enoch B. Kassa, M.D., and Yang Sun, M.D., Ph.D.

Dr. Kassa Is Resident Physician, Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, IN, and Dr. Sun is Associate Professor of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA.

Within the past 12 months, Drs. Kassa and Sun have no conflicts of interest relevant to this activity.

Albert Einstein College of Medicine, CCME staff, and interMDnet staff have nothing to disclose relevant to this activity.


Release Date: 01/16/2017
Termination Date: 01/15/2020

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Discuss the epidemiology and risk factors of open-angle glaucoma;
  • Describe the process of diagnosing open angle glaucoma;
  • Discuss the management of open angle glaucoma, the outcomes and new therapies.

 
The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity